The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study

Iyer, Shrividya; Roughley, Adam; Rider, A.; Taylor‐Stokes, Gavin

doi:10.1007/s00520-013-1959-4

Cited by 201 publications

(162 citation statements)

References 15 publications

Supporting

Mentioning

156

Contrasting

Unclassified

Order By: Relevance

“…For example, brain or bone metastases or spread to liver or to the adrenal glands or spread to the intraabdominal lymph nodes are just some of the remoted manifestations of the disease that may coexist. Coughing can be a very distressing symptom (31). It can be present in more than 65% of patients with lung cancer.…”

Section: Symptomatologymentioning

confidence: 99%

Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8^th TNM classification

Grapatsas¹,

Leivaditis²,

Tsilogianni³

et al. 2017

Oncomedicine

View full text Add to dashboard Cite

Lung cancer is a primary health issue which preoccupies the health professional community worldwide. Lung cancer is one of the leading causes of death in both men and women in the developed countries. It is mainly divided into two types. The non small cell lung cancer (NSCLC) and the small cell lung cancer (SCLC). The NSCLC is the most common type and consists the 87% of lung cancer overall. The staging and the therapeutic approach of NSCLC is based on TNM classification system. Currently the 7 th revision is being used for the appropriate classification of the cancer stadium. By the end of 2016 a new 8 th TNM classification is awaited.

show abstract

Section: Symptomatologymentioning

confidence: 99%

Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8^th TNM classification

Grapatsas¹,

Leivaditis²,

Tsilogianni³

et al. 2017

Oncomedicine

View full text Add to dashboard Cite

show abstract

“…A few underlying causes have been mentioned, including nicotine use,191 physical discomfort such as dyspnoea and increased breathing effort,192 depression, and anxiety,193 seen in COPD194 as well as in NSCLC 195, 196…”

Section: Compromised Dietary Intakementioning

confidence: 99%

Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective

Sanders¹,

Kneppers²,

Bool³

et al. 2015

Journal of Cachexia, Sarcopenia and Muscle

119

101

View full text Add to dashboard Cite

Cachexia and muscle wasting are well recognized as common and partly reversible features of chronic obstructive pulmonary disease (COPD), adversely affecting disease progression and prognosis. This argues for integration of weight and muscle maintenance in patient care. In this review, recent insights are presented in the diagnosis of muscle wasting in COPD, the pathophysiology of muscle wasting, and putative mechanisms involved in a disturbed energy balance as cachexia driver. We discuss the therapeutic implications of these new insights for optimizing and personalizing management of COPD‐induced cachexia.

show abstract

“…Basierend auf aktuellen Prävalenzangaben für die fortgeschrittene COPD (0,8 % im Alter ≥ 40 Jahre, GOLD Stadien III-IV [13]) oder den fortgeschrittenen Lungenkrebs (76 100, 5-Jahresprävalenz [27] ▶ Australien:50 % drei Monate vor Lebensende mit einem Anstieg auf 65 % in der letzten Lebenswoche [10]. In einer aktuellen multizentrischen Beobachtungsstudie über Patienten mit fortgeschrittenem Lungenkrebs in den USA (n = 450), Frankreich (n = 613) und Deutschland (n = 600) wurde jüngst eine besonders hohe Symptombelastung durch Atemnot (> 90 %) sowie ihr negativer Effekt auf die Lebensqualität dieser Patientengruppe beschrieben [18,19].…”

Section: Hintergrundunclassified

Charakteristika von Palliativpatienten mit Atemnot

Simon

Altfelder

Alt-Epping

et al. 2016

Dtsch med Wochenschr

View full text Add to dashboard Cite

Forschung, Kleinmachnow * geteilte Erstautorenschaft Zusammenfassung Hintergrund | Atemnot ist ein häufiges und belastendes Symptom bei Patienten mit fortgeschrittener lebenslimitierender Erkrankung. Das Ziel dieser Untersuchung war die Beschreibung demografischer und klinischer Charakteristika von Patienten mit Atemnot in Deutschland. Methoden | Wir führten eine Sekundäranalyse von Patientendaten der nationalen Erhebung aus spezialisierten stationären Hospiz-und Palliativeinrichtungen von 2006 bis 2008 durch. Die Hospiz-und Palliativ-Erfassung (HOPE) erhebt jährlich prospektiv deutschlandweit u .a. anhand einer validierten Checkliste standardisiert 16 Symptome und Probleme (Schweregrad 0-3).

show abstract

The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study

Abstract: Symptom burden in patients with advanced NSCLC is high and has a negative impact on the quality of life. Patient-reported outcomes data could help optimize disease outcomes and therapy management in NSCLC.

Cited by 201 publications

References 15 publications

Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8^th TNM classification

Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8^th TNM classification

Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective

Charakteristika von Palliativpatienten mit Atemnot

Contact Info

Product

Resources

About

The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study

Abstract: Symptom burden in patients with advanced NSCLC is high and has a negative impact on the quality of life. Patient-reported outcomes data could help optimize disease outcomes and therapy management in NSCLC.

Cited by 201 publications

References 15 publications

Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8th TNM classification

Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8th TNM classification

Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective

Charakteristika von Palliativpatienten mit Atemnot

Contact Info

Product

Resources

About

Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8^th TNM classification

Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8^th TNM classification